Zimmer Biomet Announces Fourth Quarter and Full-Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Zimmer Biomet (ZBH) PT Lowered to $101 at Credit Suisse
February 4, 2019 8:41 AM ESTCredit Suisse analyst Matt Miksic lowered the price target on Zimmer Biomet (NYSE: ZBH) to $101.00 (from $102.00) while maintaining a Underperform rating.
... MoreZimmer Biomet (ZBH) PT Raised to $150 at Jefferies; Train is Finally Leaving the Station
February 1, 2019 1:14 PM ESTJefferies analyst Raj Denhoy raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $140.00) while maintaining a Buy rating following strong Q4.
Denhoy said 'The Train is Leaving the Station (Finally)"
... MoreUPDATE: Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 1c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus
February 1, 2019 6:12 AM EST(Updated - February 1, 2019 6:13 AM EST)
Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.18, versus $2.17 reported last year. Revenue for the quarter came in at $2.07 billion versus the consensus estimate of $2.06 billion.
"We are encouraged with the solid close to 2018,... More
